Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Medibank Private ( (AU:MPL) ).
Medibank Private Limited announced the retirement of long-standing non-executive directors David Fagan and Linda Nicholls AO at the upcoming Annual General Meeting. Jacqueline Hey and Dr. Lisa McIntyre are nominated as their replacements, bringing extensive experience in consumer businesses, financial services, technology, health, and insurance. This board renewal is expected to strengthen Medibank’s strategic direction and support its continued growth as a leading health company.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a diversified health company that evolved from a government-owned health insurer. It operates in the healthcare industry, offering health insurance and related services, with a focus on supporting growth and development in the health sector.
Average Trading Volume: 5,372,159
Technical Sentiment Signal: Buy
Current Market Cap: A$13.83B
Find detailed analytics on MPL stock on TipRanks’ Stock Analysis page.